Practical guide for service providers on gender-responsive HIV services

HIV has long been a high-level health threat among people who inject drugs (PWID). The joint UNODC/ WHO/UNAIDS/World Bank estimate for the number of PWID worldwide for 2013 is 12.19 million (range: 8.48–21.46 million).1 About 1.65 million of those individuals are estimated to be living with HIV, a figure that corresponds to 13.5 per cent of the world’s PWID being HIV-positive. That HIV prevalence level is several times greater than among the global general population and clearly indicates that the epidemic disproportionately affects PWID wherever they live. 
The risks and potentially devastating health consequences are even greater for women, who represent in many countries a growing share of all people who inject drugs. HIV and injecting drug use are an often-ignored combination among women. As a result, women who inject drugs (WID) have less access than men to harm reduction services, even where they are in place, and are more likely than their male counterparts to acquire HIV.2 Such discrepancies underscore the urgent need for improved efforts to better reach and support all WID.
Автор: MONICA BEG, FABIENNE HARIGA, JEFF HOOVER, ZHANNAT KOSHMUKAVEDOVA: Тип видання: Методичні рекомендації Рубрика: Програма ООН